Llusern Scientific is delighted to be included as one of the point-of-care technologies being considered by the National Institute for Health and Care Excellence (NICE) for urinary tract infections to improve antimicrobial prescribing.

NICE’s guidelines are in development and can be viewed here: https://lnkd.in/ecK5Jh7r

Anyone can make a comment on the guidance. The deadline is 30 March 2023 and the final report will be made available in May 2023.

The Lodestar DX analyser and testing system is registered with the European Patent Office (European Patent Application no: 22732302.9) and the US Patent and Trademark Office (no.18/558,490).